French high court orders Merck to pay 鈧�3.3m to Levothyrox victims The court found that the lab had committed 鈥榓 fault鈥� in the final ruling on a case that dates back to 2017
French Levothyrox case forced to open in concert hall A Lyon court hearing into the ongoing case of controversial thyroid medication Levothyrox has opened in a concert hall after the city鈥檚 Palais de Justice proved too small to host the 4,113 plaintiffs present.
French Levothyrox inquiry now includes manslaughter The French inquiry into the controversial new formula of thyroid drug Levothyrox has been widened to include the charge of 鈥渋nvoluntary homicide鈥�, or manslaughter, after the death of a woman.
news Levothyrox controversy: Lyon court wins payout for patients The manufacturer of thyroid drug Levothyrox, which has been at the centre of controversy since 2017 after patients claimed a new formula did not work, has been ordered to pay 鈧�1,000 to more than 3,000 plaintiffs.
Old Levothyrox formula available in France until end of 2021 The previous formula of controversial hypothyroid medication Levothyrox is to be available in France until the end of 2021, health authority la Direction G茅n茅rale de la Sant茅 (DGS) has confirmed.
Branded medicines now only reimbursed at generic price Patients in France who refuse generic versions of their medication will now be reimbursed less, under new rules that came into force on January 1, which are expected to save the State 鈧�100 million per year.
French senator calls for new inquiry into Levothyrox A French senator has called for a new inquiry into the ongoing Levothyrox thyroid medication scandal to get 鈥渁 real view of the situation鈥�.
